Seeking Alpha

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...
Nasdaq

Tactile Medical Stock Rises After Positive Flexitouch Trial Results

Tactile Systems Technology, Inc. (TCMD), popularly known as Tactile Medical, has announced positive results from the clinical study evaluating Flexitouch advanced pneumatic compression device (APCD) ...
Yahoo Finance

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...
Nasdaq

Tactile Systems Reveals Positive Quality Of Life Endpoints For Flexitouch Device In Veterans

(RTTNews) - Tactile Systems Technology, Inc. (TCMD), Wednesday announced positive disease-specific health-related quality of life endpoints in a study of Flexitouch advanced pneumatic compression ...
Business Insider

Tactile Medical Announces New Clinical Publication Assessing the Use of Flexitouch for the Treatment of Head & Neck Lymphedema

MINNEAPOLIS, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment ...
Mena FN

Landmark Study Demonstrates Sustained Clinical Benefits Of Flexitouch® Plus As First-Line Therapy In Treating Head And Neck Cancer-Related Lymphedema

(MENAFN- GlobeNewsWire - Nasdaq) MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the“Company”) (Nasdaq: TCMD), a medical technology company ...